- Home
- AYTU vs NCI Comparison
AYTU vs NCI Comparison
Compare AYTU & NCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- NCI
- Stock Information
- Founded
- AYTU N/A
- NCI 1992
- Country
- AYTU United States
- NCI Hong Kong
- Employees
- AYTU N/A
- NCI N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- NCI
- Sector
- AYTU Health Care
- NCI
- Exchange
- AYTU Nasdaq
- NCI NYSE
- Market Cap
- AYTU 8.3M
- NCI 7.9M
- IPO Year
- AYTU N/A
- NCI 2024
- Fundamental
- Price
- AYTU $1.15
- NCI $0.48
- Analyst Decision
- AYTU
- NCI
- Analyst Count
- AYTU 0
- NCI 0
- Target Price
- AYTU N/A
- NCI N/A
- AVG Volume (30 Days)
- AYTU 37.1K
- NCI 86.2K
- Earning Date
- AYTU 05-14-2025
- NCI 05-21-2025
- Dividend Yield
- AYTU N/A
- NCI N/A
- EPS Growth
- AYTU N/A
- NCI N/A
- EPS
- AYTU N/A
- NCI 0.08
- Revenue
- AYTU $77,232,000.00
- NCI $22,481,862.00
- Revenue This Year
- AYTU N/A
- NCI N/A
- Revenue Next Year
- AYTU $8.14
- NCI N/A
- P/E Ratio
- AYTU N/A
- NCI $5.89
- Revenue Growth
- AYTU N/A
- NCI N/A
- 52 Week Low
- AYTU $1.15
- NCI $0.35
- 52 Week High
- AYTU $3.45
- NCI $11.39
- Technical
- Relative Strength Index (RSI)
- AYTU 33.76
- NCI N/A
- Support Level
- AYTU $1.20
- NCI N/A
- Resistance Level
- AYTU $1.29
- NCI N/A
- Average True Range (ATR)
- AYTU 0.06
- NCI 0.00
- MACD
- AYTU 0.00
- NCI 0.00
- Stochastic Oscillator
- AYTU 0.00
- NCI 0.00
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About NCI NEO-CONCEPT INTL GRP HLDGS LTD
Neo-Concept International Group Holdings Ltd is a company whose a one-stop apparel solution services provider. It offers a full suite of services in the apparel supply chain, including market trend analysis, product design and development, raw material sourcing, production and quality control, and logistics management serving customers located in the European, and North American markets through Neo-Concept HK.